Home
Contact Palatin
Site Map
.
.
.
.
.
.
Investor/Media Center
Overview
Press Releases
Event Calendar
Webcasts
SEC Filings
Analyst Coverage
Corporate Governance
Information Request
E-Mail Alerts
Investor Materials
Corporate Fact Sheet
Press Releases
2006
2007
2008
2009
all
2006
Displaying releases:
1-15
|
16-30
Dec-20-2006
Palatin Technologies And King Pharmaceuticals Complete Enrollment In Pre-Menopausal Cohort Of A Phase 2 Clinical Trial Evaluating Bremelanotide In Pre- And Post-Menopausal Female Sexual Dysfunction Patients
Dec-05-2006
Palatin Technologies Presents At The 9th European Society for Sexual Medicine (ESSM) Congress
Nov-10-2006
Palatin Technologies, Inc. Reports Fiscal Year 2007 First Quarter Results; Conference Call and Webcast Being Held Today at 10:00 a.m. EST
Nov-07-2006
Palatin Technologies to Report First Quarter, Fiscal Year 2007 Financial Results; Conference Call and Webcast on November 10, 2006
Nov-06-2006
Palatin Technologies and King Pharmaceuticals Report Results for Two Phase 2B Clinical Trials Evaluating Bremelanotide in Male Erectile Dysfunction Patients
Nov-03-2006
Palatin Technologies to Present at the CIBC World Markets 17th Annual Healthcare Conference
Nov-01-2006
Palatin Technologies to Present at the Rodman & Renshaw 8th Annual Healthcare Conference
Oct-13-2006
Palatin Technologies to Present at the BIO Investor Forum
Sep-22-2006
Palatin Technologies to Present at UBS 2006 Global Life Sciences Conference
Sep-13-2006
Palatin Technologies, Inc. Reports Fourth Quarter Fiscal Year End 2006 Results; Teleconference and Webcast Being Held Today at 10:00 a.m. EDT
Sep-07-2006
Palatin Technologies to Report Fourth Quarter and Year-End 2006 Financial Results; Conference Call and Webcast on September 13, 2006
Sep-06-2006
Palatin Technologies to Present at ThinkEquity Partners 4th Annual Growth Conference
Aug-30-2006
Palatin Technologies to Present at Roth Capital Partners 2006 New York Conference and Thomas Weisel Partners Healthcare Conference 2006
Aug-03-2006
Palatin Technologies and King Pharmaceuticals Report Results of a Clinical Study Evaluating Bremelanotide in Post-Menopausal Female Sexual Dysfunction Patients
Jul-28-2006
Steven Fischkoff, M.D. Joins Palatin Technologies as Vice President of Clinical Development
Overview
Press Releases
Event Calendar
Webcasts
SEC Filings
Analyst Coverage
Corporate Governance
Information Request
E-Mail Alerts
Investor Materials
Overview
Executive Management
Board of Directors
Overview
Employee Benefits
Career Opportunities
Overview
Press Releases
Presentations
Events Calendar
Webcasts
Media Kit
Overview
PL-3994 for CHF
PL-3994 for Asthma
PL-3994 for Hypertension
Bremelanotide
PL-6983
Obesity